Search hospitals
>
Ontario
>
LONDON
London Health Sciences Centre
Claim this profile
LONDON, Ontario N6A 5W9
Global Leader in Prostate Cancer
Global Leader in Cancer
Conducts research for Crohn's Disease
Conducts research for Heart Failure
Conducts research for Ulcerative Colitis
616 reported clinical trials
60 medical researchers
Summary
London Health Sciences Centre is a medical facility located in LONDON, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Crohn's Disease, Heart Failure, Ulcerative Colitis and other specialties. London Health Sciences Centre is involved with conducting 616 clinical trials across 738 conditions. There are 60 research doctors associated with this hospital, such as Michael Chu, MD, Vipul Jairath, Brent Lanting, MD, and Terry Ponich, MD, FRCPC.
Area of expertise
Prostate Cancer
London Health Sciences Centre has run 36 trials for Prostate Cancer. Some of their research focus areas include:
Cancer
London Health Sciences Centre has run 31 trials for Cancer. Some of their research focus areas include:
Top PIs
Michael Chu, MD
London Health Sciences Centre
4 years of reported clinical research
Vipul Jairath
London Health Sciences Centre
1 year of reported clinical research
Brent Lanting, MD
London Health Sciences Centre
5 years of reported clinical research
Terry Ponich, MD, FRCPC
Victoria Hospital
1 year of reported clinical research
Clinical Trials running at London Health Sciences Centre
Crohn's Disease
Chronic Kidney Disease
Heart Failure
Lung Cancer
Cancer
Obesity
Stroke
Prostate Cancer
Sarcoidosis
Heart Disease
Vedolizumab
for Ulcerative Colitis and Crohn's Disease
The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Recruiting
3 awards
Phase 3
Vedolizumab + Adalimumab/Ustekinumab
for Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual targeted treatment. The study is conducted in two parts. In Part A, participants will receive the dual targeted treatment (vedolizumab together with either adalimumab or ustekinumab). In part B, participants will receive vedolizumab only. Part B will include participants who responded to the treatment in Part A. Each participant will be followed up for at least 26 weeks after the last dose of treatment.
Recruiting
3 awards
Phase 4
10 criteria
Guselkumab
for Pediatric Crohn's Disease
This trial tests guselkumab, an anti-inflammatory medication, on children with Crohn's Disease who initially responded well to it. The goal is to see if the benefits last over several months by reducing immune system activity. Guselkumab has shown effectiveness in treating moderate-to-severe psoriasis and psoriatic arthritis.
Recruiting
2 awards
Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at London Health Sciences Centre?
London Health Sciences Centre is a medical facility located in LONDON, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Crohn's Disease, Heart Failure, Ulcerative Colitis and other specialties. London Health Sciences Centre is involved with conducting 616 clinical trials across 738 conditions. There are 60 research doctors associated with this hospital, such as Michael Chu, MD, Vipul Jairath, Brent Lanting, MD, and Terry Ponich, MD, FRCPC.
Where is London Health Sciences Centre located?
**London Health Sciences Centre** - **Address:** 339 Windermere Rd, London, ON N5X 2J9, Canada. - **Transportation:** Accessible via London Transit System Bus Route Richmond #6. Taxis available from the train station directly to the main zone B entrance.
Who should I call to ask about financial aid or insurance network?
For financial assistance at London Health Sciences Centre: - Contact the Business Office at 519-663-3146 for information on daily hospital rates and finance inquiries related to patient accounts. - For insurance-related inquiries, call the main telephone line at 519-685-8500. This line connects to various departments, including Emergency Departments, Social Work Services, and Spiritual Care. - The Patient Relations office is available at 519-685-8500 Extension: 58230 for assistance with patient rights and responsibilities.
What insurance does London Health Sciences Centre accept?
The London Health Sciences Centre (LHSC) accepts a wide range of health insurance plans, including OHIP, extended health insurance, Workplace Safety and Insurance Board, and other legally required agencies. Patients must present a valid Health Card or proof of alternative health insurance, such as UHIP, upon arrival. LHSC also collaborates with organizations across Southwestern Ontario and provincially in shared electronic patient record systems to enhance patient care continuity.
What awards or recognition has London Health Sciences Centre received?
London Health Sciences Centre (LHSC) and Lawson Health Research Institute have been awarded $5.7M in research funding for the Academic Realignment Initiative Awards. This funding is supported by private donors and LHSC's research institute. Lawson Health Research Institute is ranked eighth in Canada for research hospitals and has consistently held a top-five position in Ontario for the past six years.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.